黑料网

ISSN: 2573-542X

Cancer Surgery
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • Cancer Surg ,
  • DOI: 10.4172/2573-542X.1000036

Surgery for Management of Brain Metastases Once Previous Stop Substance Therapy

Michael Cameron*
Department of Neurosurgery, Yokohama Rosai Hospital, Yokohama, Kanagawa, Japan
*Corresponding Author : Michael Cameron, Department of Neurosurgery, Yokohama Rosai Hospital, Yokohama, Kanagawa, Japan, Email: michael.cameron22@gmail.com

Received Date: Sep 01, 2022 / Published Date: Sep 29, 2022

Abstract

Patient, tumor, and outcome knowledge were collected retrospectively from operative, radiology, pathology, and scanned documents offered through the electronic anamnesis. Demographic data for the cohort enclosed age at the time of surgery, sex, and race/ethnicity, additionally as primary cancer diagnoses, including skin cancer, nonsquamous NSCLC, breast glandular carcinoma, and excretory organ cell cancer. Surgical Performance standing (KPS) was obtained at either the surgical clinic visit or the time of admission. Surgical KPS was obtained at the time of discharge for the hospital admission related to the index surgery. Hemorrhage inside BMs was assessed with surgical resonance imaging, and solely hemorrhage inside the metastasis undergoing surgery was relevant for analysis. Extracranial malignant illness was noted at the time of surgery supported results from either total body antielectron emission pictorial representation imaging or computerized tomography imaging of the body with and while not distinction performed for staging functions surgical medical or surgical complications by thirty days once the date of surgery was noted.

Citation: Cameron M (2022) Surgery for Management of Brain Metastases Once Previous Stop Substance Therapy. Cancer Surg, 7: 036. Doi: 10.4172/2573-542X.1000036

Copyright: © 2022 Cameron M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top